|
1.
|
|
|
2.
|
|
5 p, 347.5 KB |
SEOM clinical guideline in nasopharynx cancer (2017)
/
Pastor, M. (Hospital Universitari i Politècnic La Fe (València)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
del Barco, E. (Complejo Asistencial Universitario de Salamanca) ;
Perez Segura, P. (Hospital Clínico San Carlos (Madrid)) ;
Astorga, B.G. (Hospital Universitario San Cecilio (Granada)) ;
Castelo, B. (Hospital Universitario La Paz (Madrid)) ;
Bonfill Abella, Teresa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Martinez Trufero, J. (Hospital Universitario Miguel Servet (Saragossa)) ;
Grau, Juan Jose (Hospital Clínic i Provincial de Barcelona) ;
Mesía, Ricard (Institut Català d'Oncologia) ;
Universitat Autònoma de Barcelona
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. [...]
2018 -  10.1007/s12094-017-1777-0
Clinical & Translational Oncology, Vol. 20 Núm. 1 (january 2018) , p. 84-88
|
|
|
3.
|
|
9 p, 9.3 MB |
Polybenzoxazines as new photothermal therapy agents
/
Reyes-Mateo, Kevin (Universitat Autònoma de Barcelona. Departament de Química) ;
Careta, Oriol (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Hernando Campos, Jordi (Universitat Autònoma de Barcelona. Departament de Química) ;
Nogués, Carme (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ;
Sebastián, Rosa María (Universitat Autònoma de Barcelona. Departament de Química)
To make photothermal therapy an attractive alternative to conventional cancer treatments, the development of novel photothermal agents with enhanced properties is demanded. To tackle this challenge, herein we explored the use of polybenzoxazines, a well-known class of phenolic resins. [...]
2023 - 10.1016/j.eurpolymj.2023.112531
European Polymer Journal, Vol. 201 (December 2023) , art. 112531
|
|
|
4.
|
|
28 p, 397.3 KB |
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
/
Lam, Thomas B.L. (Aberdeen Royal Infirmary) ;
MacLennan, Steven (University of Aberdeen) ;
Willemse, Peter-Paul M. (University Medical Center Utrecht) ;
Mason, Malcolm D. (Velindre Cancer Centre) ;
Plass, Karin (EAU Guidelines Office) ;
Shepherd, Robert (EAU Guidelines Office) ;
Baanders, Ruud ;
Bangma, Chris H. (Erasmus University Medical Centre) ;
Bjartell, Anders (Lund University) ;
Bossi, Alberto (Gustave Roussy Institute) ;
Briers, Erik ;
Briganti, Alberto (IRCCS Ospedale San Raffaele (Milà, Itàlia)) ;
Buddingh, Karel T. (HagaZiekenhuis) ;
Catto, James W.F. (Royal Hallamshire Hospital) ;
Colecchia, Maurizio (Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) ;
Cox, Brett W. (Zucker School of Medicine) ;
Cumberbatch, Marcus G. (University of Sheffield) ;
Davies, Jeff ;
Davis, Niall F. (Royal College of Surgeons in Ireland) ;
De Santis, Maria (Charité University Hospital) ;
Dell'Oglio, Paolo (ORSI Academy) ;
Deschamps, André (Europa Uomo) ;
Donaldson, James F. (Aberdeen Royal Infirmary) ;
Egawa, Shin (Jikei University School of Medicine) ;
Fankhauser, Christian D. (University of Zurich) ;
Fanti, Stefano (University of Bologna) ;
Fossati, Nicola (Scientific Institute and University Vita-Salute San Raffaele Hospital) ;
Gandaglia, Giorgio (IRCCS Ospedale San Raffaele) ;
Gillessen, Silke (University of Bern) ;
Grivas, Nikolaos (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Gross, Tobias (University of Bern) ;
Grummet, Jeremy P. (Monash University) ;
Henry, Ann M. (St. James's University Hospital) ;
Ingels, Alexandre (Henri Mondor Hospital) ;
Irani, Jacques (University Hospital of Bicêtre-Paris Sud-Saclay University) ;
Lardas, Michael (Department of Reconstructive Urology and Surgical Andrology) ;
Liew, Matthew (Wigan and Leigh NHS Foundation Trust) ;
Lin, Daniel W. (University of Washington) ;
Moris, Lisa (KU Leuven) ;
Omar, Muhammad Imran (University of Aberdeen) ;
Pang, Karl H. (University of Sheffield) ;
Paterson, Catherine C. (Robert Gordon University) ;
Renard-Penna, Raphaële (Sorbonne Université) ;
Ribal, María J. (Hospital Clínic i Provincial de Barcelona) ;
Roobol, M.J. (Erasmus University Medical Centre) ;
Rouprêt, Morgan (Sorbonne Université) ;
Rouvière, Olivier (Université de Lyon) ;
Sancho-Pardo, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Richenberg, Jonathan (Royal Sussex County Hospital Brighton and Brighton and Sussex Medical School) ;
Schoots, Ivo G. (Erasmus University Medical Center) ;
Sedelaar, J.P.Michiel (Radboud University Medical Centre) ;
Stricker, Phillip (Garvan Institute of Research) ;
Tilki, Derya (University Hospital Hamburg-Eppendorf) ;
Vahr Lauridsen, Susanne (Copenhagen University Hospital) ;
van den Bergh, Roderick C.N. (St. Antonius Hospital) ;
Van den Broeck, Thomas (University Hospitals Leuven (Bèlgica)) ;
van der Kwast, Theodorus H. (Erasmus University Medical Center) ;
van der Poel, Henk G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van Leenders, Geert J.L.H. (Erasmus University Medical Center) ;
Varma, Murali (University Hospital of Wales) ;
Violette, Philippe D. (McMaster University (Canadà)) ;
Wallis, Christopher J.D. (Vanderbilt University Medical Center) ;
Wiegel, Thomas (University Hospital of Ulm (Alemanya)) ;
Wilkinson, Karen (University College London Hospitals) ;
Zattoni, Fabio (Academic Medical Centre Hospital) ;
N'Dow, James M.O. (Aberdeen Royal Infirmary) ;
Van Poppel, Hendrik (University Hospitals Leuven (Bèlgica)) ;
Cornford, Philip (Royal Liverpool and Broadgreen Hospitals NHS Trust) ;
Mottet, Nicolas (University Hospital Jean Monnet) ;
Universitat Autònoma de Barcelona
There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. To develop consensus statements for all domains of DAT. [...]
2019 - 10.1016/j.eururo.2019.09.020
European Urology, Vol. 76 Núm. 6 (december 2019) , p. 790-813
|
|
|
5.
|
|
10 p, 768.8 KB |
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis : the prospective MABOMET GEICAM study
/
Barnadas i Molins, Agustí (Institut d'Investigació Biomèdica Sant Pau) ;
Muñoz, M. (Hospital Clínic i Provincial de Barcelona) ;
Margelí, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Chacón, J.I. (Hospital Virgen de la Salud (Toledo)) ;
Cassinello, J. (Hospital General de Guadalajara) ;
Antolin, S. (Complejo Hospitalario U. A Coruña) ;
Adrover, Encarna (Complejo Hospitalario Universitario de Albacete) ;
Ramos, M. (Centro Oncológico de Galicia) ;
Carrasco, E. (GEICAM (Spanish Breast Cancer Group)) ;
Jimeno, M.A. (GEICAM (Spanish Breast Cancer Group)) ;
Ojeda, Belén (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ;
González, X. (Hospital General de Catalunya) ;
González, S. (Hospital Mutua de Terrassa. Barcelona) ;
Constenla, M. (Complejo Hospitalario De Pontevedra) ;
Florián, J. (Hospital Comarcal de Barbastro) ;
Miguel, A. (Hospital Althaia Manresa) ;
Llombart, A. (Hospital Arnau de Vilanova (València)) ;
Lluch, Ana (Hospital Clínic Universitari (València)) ;
Ruiz-Borrego, M. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Colomer, R. (Hospital Universitario de la Princesa (Madrid)) ;
Del Barco, S. (Hospital Universitari de Girona Doctor Josep Trueta) ;
Universitat Autònoma de Barcelona
Bone metastasis (BM) is the most common site of disease in metastatic breast cancer (MBC) patients. BM impacts health-related quality of life (HRQoL). We tested prospectively the psychometric properties of the Bone Metastasis Quality of Life (BOMET-QoL-10) measure on MBC patients with BM. [...]
2019 - 10.1186/s41687-019-0161-y
Journal of Patient-Reported Outcomes, Vol. 3 Núm. 1 (january 2019) , p. 72
|
|
|
6.
|
|
9 p, 740.0 KB |
SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019)
/
Martín-Richard, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Carmona-Bayonas, Alberto (Hospital General Universitario Morales Meseguer (Múrcia)) ;
Custodio, A.B. (Centro de Investigación Biomédica en Red de Cáncer) ;
Gallego, J. (Hospital General Universitario de Elche) ;
Jiménez-Fonseca, P. (Hospital Universitario Central de Asturias) ;
Reina, J.J. (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Richart, P. (Hospital Universitari i Politècnic La Fe (València)) ;
Rivera, F. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Alsina, M. (Hospital Universitari Vall d'Hebron) ;
Sastre Valera, Javier (Hospital Clínico San Carlos (Madrid)) ;
Universitat Autònoma de Barcelona
Gastric cancer (GC) is the fifth most common cancer worldwide with a varied geographic distribution and an aggressive behavior. In Spain, it represents the sixth cause of cancer death. In Western countries, the incidence is decreasing slightly, with an increase in gastroesophageal junction adenocarcinoma (GEJA), a different entity that we separate specifically in the guideline. [...]
2020 - 10.1007/s12094-019-02259-9
Clinical & Translational Oncology, Vol. 22 Núm. 2 (january 2020) , p. 236-244
|
|
|
7.
|
|
14 p, 1.4 MB |
Fertility-Sparing Surgery versus Radical Hysterectomy in Early Cervical Cancer : A Propensity Score Matching Analysis and Noninferiority Study
/
Llueca, Antoni (University Jaume I (UJI)) ;
Ibañez, Maria Victoria (University Jaume I (UJI)) ;
Torne, Aureli (Hospital Clínic i Provincial de Barcelona) ;
Gil-Moreno, Antonio 1965- (Vall d'Hebron Institut d'Oncologia) ;
Martin-Jimenez, Angel (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ;
Díaz-Feijoo, Berta (Hospital Clínic i Provincial de Barcelona) ;
Serra Rubert, Anna (University Jaume I (UJI)) ;
Climent, Maria Teresa (University Jaume I (UJI)) ;
Gil-Ibañez, Blanca (Hospital 12 de Octubre (Madrid)) ;
Universitat Autònoma de Barcelona
Fertility-sparing surgery (FSS) is the treatment of choice for patients with early cervical cancer (ECC) and fertility desire, but survival rates compared to radical hysterectomy (RH) have been scarcely reported. [...]
2022 - 10.3390/jpm12071081
Journal of personalized medicine, Vol. 12 (june 2022)
|
|
|
8.
|
|
7 p, 264.1 KB |
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
/
Lee, G.A. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ;
Aktaa, S. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ;
Baker, E. (Division of Applied Technology for Clinical Care. Florence Nightingale Faculty of Nursing. Midwifery & Palliative Care. King's College London) ;
Gale, C.P. (Department of Cardiology. Leeds Teaching Hospitals NHS Trust) ;
Yaseen, I.F. (Scientific Council of Cardiology. Iraqi Board for Medical Specializations) ;
Gulati, G. (Oslo University Hospital (Oslo, Noruega)) ;
Asteggiano, R. (LARC (Laboratorio Analisi e Ricerca Clinica)) ;
Szmit, S. (Institute of Hematology and Transfusion Medicine) ;
Cohen-Solal, A. (Cardiology Department. Hôpitaux de Paris. Hôpital Lariboisière 2 Rue Ambroise Paré) ;
Abdin, A. (Department of Internal Medicine III. Cardiology. Angiology. Intensive Care Medicine. Saarland University Medical Center) ;
Jurczak, W. (MSC National Research Institute of Oncology) ;
Garrido, Pilar (Jefe Servicio Oncología Médica. Hospital Ramón y Cajal) ;
Sverdlov, A.L. (Newcastle Centre of Excellence in Cardio-Oncology. Calvary Mater Newcastle. Hunter Medical Research Institute. John Hunter Hospital. University of Newcastle) ;
Tocchetti, C.G. (Cardio-Oncology Unit. Department of Translational Medical Sciences (DISMET). Center for Basic and Clinical Immunology Research (CISI). Interdepartmental Center for Clinical and Translational Research (CIRCET). Interdepartmental Hypertension Research Center (CIRIAPA). Federico II University) ;
Barac, A. (Cardio-oncology Program. MedStar Heart and Vascular Institute) ;
Parrini, I. (Department of Cardiology. Mauriziano Hospital) ;
Zamorano, P. (Hospital Universitario Ramón y Cajal (Madrid)) ;
Iakobishvili, Z. (Faculty of Health Sciences. Ben Gurion University of the Negev) ;
Pudil, R. (University Hospital Hradec Králové. Sokolská) ;
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ;
Kirby, A.M. (Royal Marsden NHS Trust. Institute of Cancer Research) ;
Blaes, A.H. (Division of Hematology/Oncology/Transplantation. University of Minnesota) ;
Farmakis, D. (University of Cyprus Medical School) ;
Curigliano, Giuseppe (IRCCS. European Institute of Oncology) ;
Stephens, R. (Patient Advocate) ;
Lyon, A.R. (National Heart and Lung Institute. Imperial College London. Cardio-Oncology Service. Royal Brompton Hospital) ;
Lopez-Fernandez, T. (Hospital Universitario La Paz. Instituto de Investigación IdiPAZ. Servicio de Cardiología)
Aims To develop quality indicators (QIs) for the evaluation of the prevention and management of cancer therapy-related cardiovascular toxicity. Methods and results We followed the European Society of Cardiology (ESC) methodology for QI development which comprises (i) identifying the key domains of care for the prevention and management of cancer therapy-related cardiovascular toxicity in patients on cancer treatment, (ii) performing a systematic review of the literature to develop candidate QIs, and (iii) selecting of the final set of QIs using a modified Delphi process. [...]
2023 - 10.1093/ehjqcco/qcac070
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9 Núm. 1 (january 2023) , p. 1-7
|
|
|
9.
|
|
7 p, 445.9 KB |
Small renal masses in kidney transplantation : Overview of clinical impact and management in donors and recipients
/
Piana, Alberto (Fundació Puigvert) ;
Andras, Iulia (Iuliu Hatieganu University of Medicine and Pharmacy and Municipal Hospital) ;
Diana, Pietro (Fundació Puigvert) ;
Verri, Paolo (Fundació Puigvert) ;
Gallioli, Andrea (Fundació Puigvert) ;
Campi, Riccardo (University of Florence) ;
Prudhomme, Thomas (Toulouse University Hospital) ;
Hevia, Vital (Hospital Universitario Ramón y Cajal (Madrid)) ;
Boissier, Romain (Aix-Marseille université) ;
Breda, Alberto (Fundació Puigvert) ;
Territo, Angelo (Fundació Puigvert) ;
Universitat Autònoma de Barcelona
Kidney transplantation is the best replacement treatment for the end-stage renal disease. Currently, the imbalance between the number of patients on a transplant list and the number of organs available constitutes the crucial limitation of this approach. [...]
2022 - 10.1016/j.ajur.2022.06.001
Asian Journal of Urology, Vol. 9 (june 2022) , p. 208-214
|
|
|
10.
|
|
16 p, 1.4 MB |
Changes in Treatment Patterns and Costs for Lung Cancer Have Not Resulted in Relevant Improvements in Survival : A Population-Based Observational Study in Catalonia
/
Guarga, Laura (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ;
Paco, Noelia (Servei Català de la Salut) ;
Vela, Emili (Institut d'Investigació Biomèdica de Bellvitge) ;
Cleries, Montserrat (Institut d'Investigació Biomèdica de Bellvitge) ;
Corral, Julieta (Institut d'Investigació Biomèdica de Bellvitge) ;
Delgadillo Duarte, Joaquin (Banc de Sang i Teixits) ;
Pontes García, Caridad (Institut d'Investigació Biomèdica de Bellvitge) ;
Borras, Josep M (Universitat de Barcelona)
Real-world data collect clinical and economic information from daily clinical practice and can support decisions in the context of health evaluation and management. The aim of our retrospective cohort study was to describe the different approaches used for treating lung cancer in Catalonia in 2014 and 2018 and to assess the associated cost and impact on patient survival until December 2021. [...]
2022 - 10.3390/cancers14235791
Cancers, Vol. 14 (november 2022)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
